Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Interventions

Temozolomide 79 Magnetic Resonance Spectroscopy 68 Specimen Handling 45 Radiotherapy 42 Bevacizumab 29 Radiosurgery 27 Cyclophosphamide 27 Radiation 20 pembrolizumab 19 Blood Specimen Collection 19 fludarabine 16 Nivolumab 16 Irinotecan 15 Carboplatin 13 Biopsy 13 Etoposide 12 Vincristine 11 Pemetrexed 11 Lomustine 11 dinutuximab 9 Surgical Procedures, Operative 9 trametinib 8 abemaciclib 8 Ipilimumab 8 naxitamab 7 fluciclovine F-18 7 Watchful Waiting 7 Topotecan 7 Proton Therapy 7 Magnetic Resonance Imaging 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cell Count × CNS × Clear all

NCT07144735 2025-08-27

ABOUT

Peking University Third Hospital

Phase NA Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡